Stock Report

Shree Ganesh Biotech India Ltd Q2 FY2022-23 profit at Rs. 1.20 crore



Posted On : 2022-11-09 21:58:14( TIMEZONE : IST )

Shree Ganesh Biotech India Ltd Q2 FY2022-23 profit at Rs. 1.20 crore

has reported Standalone financial results for the period ended September 30, 2022.

Financial Results (Q2 FY2023) - QoQ Comparison

The company has reported total income of Rs. 21.7704 crores during the period ended September 30, 2022 as compared to Rs. 20.6132 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs. 1.2001 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 1.1484 crores for the period ended June 30, 2022.

The company has reported EPS of Rs. 0.03 for the period ended September 30, 2022 as compared to Rs. 0.03 for the period ended June 30, 2022.

Financials Q2 FY2023 Q1 FY2023 % Change
Total Income ₹ 21.7704 crs ₹20.6132 crs Up Tick / Down Tick5.61%
Net Profit ₹1.2001 crs ₹1.1484 crs Up Tick / Down Tick4.50%
EPS ₹0.03 ₹0.03 Up Tick / Down Tick0.00%

Financial Results (Q2 FY2023) - YoY Comparison

The company has reported total income of Rs. 21.7704 crores during the period ended September 30, 2022 as compared to Rs.17.9618 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.1.2001 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.0.8241 crores for the period ended September 30, 2021.

The company has reported EPS of Rs.0.03 for the period ended September 30, 2022 as compared to Rs..41 for the period ended September 30, 2021.

Financials Q2 FY2023 Q2 FY2022 % Change
Total Income ₹ 21.7704 crs ₹17.9618 crs Up Tick / Down Tick21.20%
Net Profit ₹1.2001 crs ₹0.8241 crs Up Tick / Down Tick45.63%
EPS ₹0.03 ₹.41 Up Tick / Down Tick-92.68%

Financial Results (Half Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.42.3836 crores during the 6 Months period ended September 30, 2022 as compared to Rs.33.5243 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.2.3485 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.1.5063 crores for the 6 Months period ended September 30, 2021.

The company has reported EPS of Rs..06 for the 6 Months period ended September 30, 2022 as compared to Rs.0.76 for the 6 Months period ended September 30, 2021.

Financials Half Year Ended FY2023 Half Year Ended FY2022 % Change
Total Income ₹42.3836 crs ₹33.5243 crs Up Tick / Down Tick26.43%
Net Profit ₹2.3485 crs ₹1.5063 crs Up Tick / Down Tick55.91%
EPS ₹.06 ₹0.76 Up Tick / Down Tick-92.11%

Source : Equity Bulls

Keywords

ShreeGaneshBiotechIndia Q2FY23 H1FY23 ResultUpdate